268 related articles for article (PubMed ID: 9063681)
1. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
Fenu S; Pinna A; Ongini E; Morelli M
Eur J Pharmacol; 1997 Feb; 321(2):143-7. PubMed ID: 9063681
[TBL] [Abstract][Full Text] [Related]
2. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
Pinna A; Fenu S; Morelli M
Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats.
Carta AR; Pinna A; Tronci E; Morelli M
Neurology; 2003 Dec; 61(11 Suppl 6):S39-43. PubMed ID: 14663008
[TBL] [Abstract][Full Text] [Related]
4. Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors.
Fenu S; Morelli M
Eur J Neurosci; 1998 May; 10(5):1878-84. PubMed ID: 9751157
[TBL] [Abstract][Full Text] [Related]
5. Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats.
Pinna A; di Chiara G; Wardas J; Morelli M
Eur J Neurosci; 1996 Jun; 8(6):1176-81. PubMed ID: 8752587
[TBL] [Abstract][Full Text] [Related]
6. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
7. Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.
Morelli M; Pinna A
Neurol Sci; 2001 Feb; 22(1):71-2. PubMed ID: 11487207
[TBL] [Abstract][Full Text] [Related]
8. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons.
Svenningsson P; Fourreau L; Bloch B; Fredholm BB; Gonon F; Le Moine C
Neuroscience; 1999 Mar; 89(3):827-37. PubMed ID: 10199616
[TBL] [Abstract][Full Text] [Related]
9. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
10. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
11. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
Synapse; 2008 May; 62(5):345-51. PubMed ID: 18297692
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
Morelli M; Fenu S; Pinna A; Di Chiara G
J Pharmacol Exp Ther; 1992 Jan; 260(1):402-8. PubMed ID: 1346165
[TBL] [Abstract][Full Text] [Related]
13. A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.
Acquas E; Fenu S; Loddo P; Di Chiara G
Behav Brain Res; 1999 Sep; 103(2):219-28. PubMed ID: 10513590
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats.
Morelli M; Pinna A; Wardas J; Di Chiara G
Neuroscience; 1995 Jul; 67(1):49-55. PubMed ID: 7477908
[TBL] [Abstract][Full Text] [Related]
15. Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.
Popoli P; Reggio R; Pèzzola A
Neuropsychopharmacology; 2000 May; 22(5):522-9. PubMed ID: 10731627
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.
Pinna A; Wardas J; Cristalli G; Morelli M
Brain Res; 1997 Jun; 759(1):41-9. PubMed ID: 9219861
[TBL] [Abstract][Full Text] [Related]
17. Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study.
Fenu S; Acquas E; Di Chiara G
Neurol Sci; 2001 Feb; 22(1):63-4. PubMed ID: 11487203
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
Carta AR; Pinna A; Cauli O; Morelli M
Synapse; 2002 Jun; 44(3):166-74. PubMed ID: 11954048
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
Le Moine C; Svenningsson P; Fredholm BB; Bloch B
J Neurosci; 1997 Oct; 17(20):8038-48. PubMed ID: 9315922
[TBL] [Abstract][Full Text] [Related]
20. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Paul ML; Graybiel AM; David JC; Robertson HA
J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
